期刊文献+

溃疡性结肠炎组织中核因子-kB和白细胞介素-13的表达及其意义

Expressions of Nuclear Factor kB and Interleukin - 13 in Colon Tissues of Ulcerative Colitis and Its Implication
原文传递
导出
摘要 目的研究核因子-kBp65(nuclear factor kB p65,NF—kBp65)、白细胞介素-13(IL-13)在溃疡性结肠炎(UC)结肠组织中的表达、分布,以及与UC病变程度的关系,探讨它们在UC发生发展中的作用。方法分别用免疫组化SP法和ELISA法检测活动期UC(46例)及正常对照(28例)组织中NF—kBp65和IL-13的表达情况。结果UC组结肠粘膜NF—kBp65的表达活性明显高于正常对照组,二组间有显著性差异(P〈0.05),而IL-13表达水平明显低于正常对照组(P〈0.01)。UC病情程度越重,NF—KBp65表达的阳性率越高,而IL-13表达越低,NF—kBp65和IL-13表达具有明显的负相关性(r=-0.768,P〈0.01)。结论NF—kBp65的表达与IL-13呈负相关,均参与了UC的发生和发展。NF—kBp65、IL—13反映了疾病的炎症程度,并且可作为病情严重程度评定的指标。IL-13的表达可能由NF—kBp65调控。 Objective To determine the levels of nuclear factor kB 1365 ( NF - kB p65 ) and interleukin - 13 (IL- 13)in colon tissue of patients with ulcerative colitis(UC) and to explore the relationship among the expressions of NF - kB p65 and IL - 13 and the severity of disease. Methods The levels of NF - kB p65 and IL - 13 in colon mucosa of UC patients were detected by immunohistochemistry method and ELISA respectively. Results The levels of NF - kB p65 in colon mucosa of UC patients were much higher than that of normal controls. The expressions of NF - kB p65 of UC patients were higher in involved mucosa than in corresponding normal mucosa. The levels of IL - 13 in colon mucosa of UC patients were much lower than that of normal controls. The expressions of IL - 13of UC patients were lower in involved mucosa than in corresponding normal mucosa. The expressions of NF - kB 1365 and IL - 13 were related to the extent of lesion and the degree of disease. The expression of NF - kB p65 was significantly nega- tive correlated with that of IL - 13 ( r = - 0. 768,P 〈 0. O1 ). Conclusions The induction of NF - kB p65 and IL - 13 was involved in process of inflammation and development of UC. Regulating mechanisms of IL - 13 expression may be related with the induction of NF - kB 1o65.
出处 《医学新知》 CAS 2011年第4期251-253,256,共4页 New Medicine
关键词 核因子-KB 白细胞介素-13 溃疡性结肠炎 Ulcerative colitis Nuclear factor kB Interleukin - 13
  • 相关文献

参考文献10

  • 1欧阳钦,胡品津,钱家鸣,郑家驹,胡仁伟.对我国炎症性肠病诊断治疗规范的共识意见[J].胃肠病学,2007,12(8):488-495. 被引量:751
  • 2Truelove S C ,Witts I J. Cortisone in ulcerative colitis. Report on therapeutic trial [ J ]. BMJ, 1955,2 : 1041.
  • 3Schroeder K W,Tremaine W J, Ilstrup D M. Coated oral 5 - aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study[ J]. N Engl J Med, 1987,317 (26) : 1625- 1629.
  • 4Schreiber S, Nikolaus S, Hampe J. Activation of nuclear factor kappa B inflammatory bowel disease [ J ]. Gut, 1998,42 ( 4 ) :477-484.
  • 5Andresen L, Jorgensen V L, Perner A, et al. Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis[ J]. Gut,2005,54(4) :503-509.
  • 6Vainer B, Nielsen O H, Hendel J, et al. Colonic expression and synthesis of intedeukin IL - 13 and intedeukin 15 in inflammatory bowel disease [ J ]. Cytokine,2000,12 ( 10), 1531-1536.
  • 7Kadivar K,Ruchelli E D, Markowitz J E, et al. Intestinal interleukin -13 in pediatric inflammatory bowel disease patients[ J ]. lnfiamm Bowel Dis,2004,10(5 ) :593-598.
  • 8Brandtzaeg P. Inflammatory bowel disease:clinics and pathology. Do inflammatory bowel disease and periodontal disease have similar immunopathogeneses? [ J ]. Acta Odonto| Scand, 2001,59 ( 4 ) : 235- 243.
  • 9Chapoval S P, AIGarawi A, Lora J M, et al. Inhibition of NF - kappab activation reduces the tissue effects of transgenic IL- 13 [ J ]. J Immunol,2007,179 (10) :7030-7041.
  • 10Shinozaki S, Mashima H,Ohnishi H, et al. IL- 13 promotes the proliferation of rat pancreatic stellate cells through the suppression of NF - kappaB/TGF - beta1 pathway [ J ]. Biochem Biophys Res Commun ,2010,393( 1 ) :61--65.

二级参考文献18

  • 1潘国宗 刘彤华 见:潘国宗 曹世植9. 主编.溃疡性结肠炎[A].见:潘国宗,曹世植9.,主编.现代胃肠病学.第Ⅰ版[C].北京:科学出版社,1994.1246-1247.
  • 2潘国宗 刘彤华.Crohn病[A].见:潘国宗 曹世植 主编.现代胃肠病学[C].北京:科学出版社,1994.1154.
  • 3Ouyang Q,Tandon R,Goh KL,et al.The emergence of inflammatory bowel disease in the Asian Pacific region.Curr Opin Gastroenterol,2005,21 (4):408-413.
  • 4Satsangi J,Silverberg MS,Vermeire S,et al.The Montreal classification of inflammatory bowel disease:controversies,consensus,and implications.Gut,2006,55(6):749-753.
  • 5Kornbluth A,Sachar DB; Practice Parameters Committee of the American College of Gastroenterology.Ulcerative colitis practice guidelines in adults (update):American College of Gastroenterology,Practice Parameters Committee.Am J Gastroenterol,2004,99 (7):1371-1385.
  • 6Hanauer SB,Sandborn W; Practice Parameters Committee of the American College of Gastroenterology.Management of Crohn's disease in adults.Am J Gastroenterol,2001,96 (3):635-643.
  • 7Stange EF,Travis SP,Vermeire S,et al.European Crohn's and Colitis Organisation.European evidence based consensus on the diagnosis and management of Crohn's disease:definitions and diagnosis.Gut,2006,55Suppl 1:i1-i15.
  • 8Carter MJ,Lobo AJ,Travis SP; IBD Section,British Society of Gastroenterology.Guidelines for the management of inflammatory bowel disease in adults.Gut,2004,53 Suppl 5:V1-V16.
  • 9Shivananda S,Hordijk ML,Ten Kate FJ,et al.Differential diagnosis of inflammatory bowel disease.A comparison of various diagnostic classifications.Scand J Gastroenterol,1991,26 (2):167-173.
  • 10樋渡信夫 渡边浩光 前川浩树 等.溃疡性结肠炎的诊断标准与诊断进展[J].炎症性肠疾患胃与肠,1997,32(3):271-278.

共引文献750

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部